Zinc in PDB 5sgh: Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine, PDB code: 5sgh
was solved by
C.Joseph,
J.Benz,
A.Flohr,
K.Groebke-Zbinden,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.48 /
1.97
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
134.991,
134.991,
234.187,
90,
90,
120
|
R / Rfree (%)
|
17.7 /
22
|
Other elements in 5sgh:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
(pdb code 5sgh). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine, PDB code: 5sgh:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sgh
Go back to
Zinc Binding Sites List in 5sgh
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:30.9
occ:1.00
|
O
|
A:HOH983
|
2.1
|
24.7
|
1.0
|
OD1
|
A:ASP674
|
2.1
|
28.1
|
1.0
|
OD2
|
A:ASP564
|
2.1
|
25.9
|
1.0
|
NE2
|
A:HIS529
|
2.2
|
28.1
|
1.0
|
NE2
|
A:HIS563
|
2.2
|
24.1
|
1.0
|
O
|
A:HOH977
|
2.3
|
33.0
|
1.0
|
CG
|
A:ASP674
|
3.1
|
29.5
|
1.0
|
CD2
|
A:HIS563
|
3.1
|
24.1
|
1.0
|
CG
|
A:ASP564
|
3.1
|
25.9
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
28.5
|
1.0
|
CE1
|
A:HIS529
|
3.2
|
26.3
|
1.0
|
CE1
|
A:HIS563
|
3.3
|
28.6
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
32.9
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
25.9
|
1.0
|
MG
|
A:MG802
|
3.7
|
26.6
|
1.0
|
O
|
A:HOH1015
|
4.1
|
29.1
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
28.4
|
1.0
|
O
|
A:HOH948
|
4.2
|
35.0
|
1.0
|
CG
|
A:HIS563
|
4.3
|
26.8
|
1.0
|
CG
|
A:HIS529
|
4.3
|
27.2
|
1.0
|
ND1
|
A:HIS529
|
4.3
|
26.7
|
1.0
|
CB
|
A:ASP564
|
4.3
|
25.8
|
1.0
|
ND1
|
A:HIS563
|
4.4
|
27.8
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
30.2
|
1.0
|
CB
|
A:ASP674
|
4.4
|
25.2
|
1.0
|
O
|
A:HOH1019
|
4.5
|
44.2
|
1.0
|
O
|
A:HOH952
|
4.5
|
23.2
|
1.0
|
CG2
|
A:VAL533
|
4.8
|
21.8
|
1.0
|
CA
|
A:ASP674
|
4.8
|
24.5
|
1.0
|
O
|
A:ASP674
|
4.8
|
26.7
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sgh
Go back to
Zinc Binding Sites List in 5sgh
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:29.2
occ:1.00
|
O
|
B:HOH957
|
2.1
|
19.1
|
1.0
|
OD1
|
B:ASP674
|
2.1
|
25.4
|
1.0
|
NE2
|
B:HIS563
|
2.1
|
22.5
|
1.0
|
OD2
|
B:ASP564
|
2.1
|
24.3
|
1.0
|
NE2
|
B:HIS529
|
2.1
|
23.5
|
1.0
|
O
|
B:HOH986
|
2.3
|
33.2
|
1.0
|
CG
|
B:ASP674
|
3.0
|
26.9
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
22.8
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
24.4
|
1.0
|
CG
|
B:ASP564
|
3.1
|
26.0
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
27.3
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
23.7
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
27.6
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
23.8
|
1.0
|
MG
|
B:MG802
|
3.7
|
22.6
|
1.0
|
O
|
B:HOH1022
|
3.9
|
23.7
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
27.8
|
1.0
|
CG
|
B:HIS563
|
4.2
|
23.2
|
1.0
|
O
|
B:HOH941
|
4.2
|
35.7
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
24.2
|
1.0
|
CG
|
B:HIS529
|
4.3
|
23.9
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
22.0
|
1.0
|
CB
|
B:ASP564
|
4.3
|
23.6
|
1.0
|
CB
|
B:ASP674
|
4.3
|
23.9
|
1.0
|
NE2
|
B:HIS525
|
4.4
|
29.6
|
1.0
|
O
|
B:HOH1032
|
4.4
|
38.6
|
1.0
|
O
|
B:HOH966
|
4.6
|
21.9
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
23.4
|
1.0
|
CA
|
B:ASP674
|
4.8
|
24.6
|
1.0
|
O
|
B:ASP674
|
4.9
|
22.3
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sgh
Go back to
Zinc Binding Sites List in 5sgh
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:31.3
occ:1.00
|
O
|
C:HOH940
|
2.0
|
22.1
|
1.0
|
OD2
|
C:ASP564
|
2.1
|
24.6
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
23.8
|
1.0
|
OD1
|
C:ASP674
|
2.1
|
26.1
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
27.0
|
1.0
|
O
|
C:HOH1019
|
2.2
|
36.2
|
1.0
|
CG
|
C:ASP674
|
3.0
|
27.9
|
1.0
|
CD2
|
C:HIS563
|
3.0
|
24.5
|
1.0
|
CG
|
C:ASP564
|
3.1
|
25.0
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
26.9
|
1.0
|
CE1
|
C:HIS529
|
3.1
|
26.6
|
1.0
|
OD2
|
C:ASP674
|
3.2
|
33.8
|
1.0
|
CE1
|
C:HIS563
|
3.2
|
25.1
|
1.0
|
OD1
|
C:ASP564
|
3.5
|
23.5
|
1.0
|
MG
|
C:MG802
|
3.7
|
25.4
|
1.0
|
O
|
C:HOH1037
|
4.0
|
25.1
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
30.1
|
1.0
|
CG
|
C:HIS563
|
4.2
|
23.8
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
24.8
|
1.0
|
CG
|
C:HIS529
|
4.3
|
24.2
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
26.4
|
1.0
|
CB
|
C:ASP564
|
4.3
|
24.2
|
1.0
|
O
|
C:HOH1002
|
4.3
|
37.6
|
1.0
|
CB
|
C:ASP674
|
4.4
|
26.3
|
1.0
|
O
|
C:HOH1014
|
4.4
|
45.0
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
30.4
|
1.0
|
O
|
C:HOH974
|
4.6
|
25.7
|
1.0
|
CA
|
C:ASP674
|
4.8
|
29.1
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
25.5
|
1.0
|
O
|
C:ASP674
|
4.9
|
27.7
|
1.0
|
O
|
C:HOH943
|
5.0
|
24.5
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sgh
Go back to
Zinc Binding Sites List in 5sgh
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 4-[1- Methyl-6-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Pyrazolo[3,4- D]Pyrimidin-4-Yl]Morpholine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:35.3
occ:1.00
|
O
|
D:HOH950
|
2.0
|
25.4
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
25.1
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
33.8
|
1.0
|
O
|
D:HOH985
|
2.2
|
37.8
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
33.6
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
27.0
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
27.1
|
1.0
|
CG
|
D:ASP564
|
3.1
|
28.2
|
1.0
|
CG
|
D:ASP674
|
3.1
|
31.6
|
1.0
|
CD2
|
D:HIS529
|
3.1
|
38.9
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
33.9
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
35.7
|
1.0
|
CE1
|
D:HIS563
|
3.3
|
27.2
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
32.4
|
1.0
|
MG
|
D:MG802
|
3.7
|
32.7
|
1.0
|
O
|
D:HOH996
|
4.1
|
31.9
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
38.4
|
1.0
|
CG
|
D:HIS563
|
4.2
|
26.6
|
1.0
|
CB
|
D:ASP564
|
4.2
|
29.6
|
1.0
|
O
|
D:HOH941
|
4.3
|
41.4
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
30.9
|
1.0
|
CG
|
D:HIS529
|
4.3
|
34.5
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
27.3
|
1.0
|
CB
|
D:ASP674
|
4.4
|
30.2
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
39.9
|
1.0
|
O
|
D:HOH934
|
4.6
|
32.2
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
35.3
|
1.0
|
O
|
D:ASP674
|
4.8
|
28.2
|
1.0
|
CA
|
D:ASP674
|
4.9
|
28.7
|
1.0
|
|
Reference:
A.Flohr,
D.Schlatter,
B.Kuhn,
M.G.Rudolph.
Crystal Structure of A Human Phosphodiesterase 10 Complex To Be Published.
Page generated: Mon Oct 28 05:12:49 2024
|